Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2021-06-02 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
关于天康转债转股价格调整的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Tian Kang Biological Co., Ltd. regarding the adjustment of the conversion price of its convertible bonds (referred to as 'Tian Kang Convertible Bonds'). It includes detailed information about the bond issuance, regulatory approvals, the formula for adjusting the conversion price, and the specific adjustment effective date. The document is a formal disclosure of a capital/financing update related to convertible bond terms, not a full financial report or earnings release. It does not contain financial statements or management discussion but focuses on bond conversion price adjustment, which is a capital structure change. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 2253 characters, consistent with an announcement rather than a full report.
2021-06-02 Chinese
2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2020 annual equity distribution (dividend) plan approved at the 2020 annual general meeting. It details the dividend amount per share, the record date, the ex-dividend date, the distribution method, and related adjustments to convertible bond conversion prices. It does not contain full financial statements or comprehensive financial performance data, but rather focuses on dividend distribution details. This fits the definition of a Notice of Dividend Amount (DIV). The document length is 2576 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is DIV with high confidence.
2021-06-02 Chinese
关于天康转债暂停转股的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Tian Kang Biological Co., Ltd. regarding the suspension and resumption of convertible bond conversion rights, including details about the adjustment of the conversion price. It references specific bond codes, dates for suspension and resumption of conversion, and includes regulatory compliance statements. The document is short (1474 characters) and serves as a notification about bond conversion terms and related corporate actions rather than a full financial report or detailed financial data. It does not contain comprehensive financial statements or management discussion. Therefore, it fits best as a Capital/Financing Update (CAP) since it relates to convertible bond terms and capital structure changes.
2021-05-31 Chinese
关于收到中国证监会核准非公开发行股票批复的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tian Kang Bio Co., Ltd. regarding the receipt of approval from the China Securities Regulatory Commission (CSRC) for a non-public issuance of shares. It details the approval number, the number of shares to be issued, validity period, and compliance requirements. The document is short (633 characters) and serves as a formal notification of a capital raising event (non-public share issuance). It does not contain financial statements or detailed financial data, nor is it a full report. Therefore, it fits the category of Capital/Financing Update (CAP).
2021-05-27 Chinese
2020年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2020 Annual General Meeting (AGM) resolution announcement for Tian Kang Biological Co., Ltd. It details the date and method of the meeting, attendance, and the voting results on various proposals including approval of the 2020 annual report, board work report, financial statements, profit distribution plan, and appointment of auditors. The document primarily reports the voting results and resolutions passed at the AGM rather than containing the full annual report or financial statements themselves. The length is 4453 characters, which is relatively short and consistent with an announcement of voting results rather than the full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-14 Chinese
新疆星河律师事务所关于天康生物股份有限公司2020年年度股东大会之法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2020 Annual General Meeting (AGM) of Tian Kang Bio. It discusses the legality of the meeting's convening, attendance, voting procedures, and resolutions passed. It references the 2020 Annual General Meeting specifically and does not contain financial statements or detailed financial data. The document is not the AGM materials themselves but a legal opinion related to the AGM. Given the content and purpose, this fits best under AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including legal opinions related to the meeting.
2021-05-14 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.